Sanofi Pasteur Update Regarding COVID-19 (March 2020)
CCPA Purchasing Parnters (CCPAPP) and Sanofi Pasteur would like to provide our members with an update as it relates to Sanofi Pasteur's response to the COVID-19 (Coronavirus) outbreak:
- Sanofi Pasteur is fully operational and continues to fulfill orders
- All face-to-face interactions with customers have been suspended until further notice per Centers for Disease Control and Prevention’s Guidelines (If you are unable to click the link, please copy and paste the following into your browser: https://www.cdc.gov/coronavirus/2019-ncov/downloads/community-mitigation-strategy.pdf)
- Support is available to help meet your vaccine needs by contacting 1-800-VACCINE (1.800.822.2463) or your Sanofi Pasteur Vaccine Representative
- Please review Sanofi’s Response to COVID-19 which outlines their approach to the crisis including the work to develop a vaccine (if you are unable to click the link, please copy and paste the following into your browser: https://www.sanofi.us/en/about-us/our-stories/our-response-to-covid-19)
Lastly, as previously posted on our news site, Sanofi Pasteur has extended the 2020-2021 influenza vaccine reservation deadline from March 31 to April 30, 2020. Please read Sanofi Pasteur's Customer Letter for more details.
For questions regarding this update, please contact your Sanofi Pasteur Vaccine Sales Representative or Priya Stemler, Director of Operations for CCPA Purchasing Partners, at pstemler@ccpapp.org.
We wish you and your practice all the best as you work to provide the best possible care to your patients during this challenging time!
« Back